Trends in vaccinology for (re)emerging pathogens
Website to register (deadline May 18 midnight UTC/GMT+2):
http://vaxinlive.univ-lyon1.fr
| SCHEDULE UTC+2 | SESSION TITLE |
| 08:30 – 08:45 |
Welcome - Christine Delprat
|
|
08:45 – 09:00
|
Inés Có Rives (ES) / Zuzanna Piwowarska (PL), IVAA, Lyon (FR)
MSc, IVAA President / MSc, IVAA Communication Manager
Montagu Alumni LIVE 2020 Graduates
International Vaccinologist Alumni Association (IVAA): facts, future, Q & A
|
|
09:00 – 09:15
|
Saddam Mohammed Ibrahim / Anmaw Shite Abat, DVM, MSc, vaccinologists, University of Gondar (ET)
Jenner Alumni LIVE 2018 Graduates
The first MSc in Veterinary Immunology in Ethiopian Universities
|
|
09:15 – 10:15
|
Session 1: Acute emerging disease environment - Sakshi Jindal & Luc Kestens
|
|
09:15 – 09:45
|
Mark Doherty, PhD, Senior Medical Manager, GSK, Copenhagen (DK) and Wavre (BE)
Downstream effects of vaccination: beyond acute disease
|
|
09:45 – 10:15
|
Simon Graham, Professor & Group Leader, The Pirbright Institute (UK)
Developing a “One Health” Nipah virus vaccine to protect animal and public health
|
|
10:15 – 10:30
|
Coffee break
|
|
10:30 – 12:00
|
Session 2: Infodemiology – the practice and science - Sakshi Jindal & Tim Nguyen
|
|
10:30 – 10:45
|
Christine Czerniak, PhD, Technical Lead for Infodemic Management, WHO, Geneva (CH)
Introduction to infodemic management
|
|
10:45 – 11:00
|
Sara Rubinelli, Professor of Health Communication, Department of Health Sciences and Medicine, University of Lucerne (CH)
Infodemic management competency framework
|
|
11:00 – 11:15
|
Lynette Phuong, MPH, Technical Officer for Infodemic Management, WHO, Geneva (CH)
Overview of training opportunities
|
|
11:15 – 11:30
|
Cherstyn Hurley, PhD, National Immunisation programme publications manager, Public Health England (UK)
Applying infodemiology to increase vaccine uptake
|
|
11:30 – 11:45
|
Avichal Mahajan, PhD, Technical Officer for Data Management, World Health Organization, Geneva (CH)
Knowledge gaps – Infodemic research agenda
|
|
11:45 – 12:00
|
Q & A on infodemiology
|
|
12:00 – 14:00
|
Lunch break
|
|
13:00 – 14:00
|
Françoise Barré-Sinoussi, Senior Scientist, Nobel Prize Laureate in Medicine and Physiology, Pasteur Institute (FR), animated by Stéphane Paul.
Pandemics, Research & Future, Q & A closed session for 50 students
|
|
14:00 – 15:00
|
Session 3 Preclinical and Tech transfer vaccine challenges - Dennis Giron & Thomas Stratmann
|
|
14:00 – 14:40
|
Rajko Reljic, Professor in Immunology, Institute for Infection and Immunity, St George’s University of London(UK)
From mice to monkeys: successes and challenges in mucosal TB vaccine development
|
|
14:40 – 15:00
|
Tiago Rocca, Head of Strategic Partnerships and Business Development at Instituto Butantan, São Paulo (BR)
Tech Transfer agreement and steps for establishment of production of the CoronaVac vaccine
|
|
15:00 – 15:30
|
Session 4: Phd student Junior talks - Julie Bigay & Nicolas Rochereau
|
|
15:00 – 15:10
|
Patrícia Gonzalez-Dias, PhD Student, MSc, School of Pharmaceutical Sciences - Universidade de São Paulo - FCF-USP (BR)
Systems Vaccinology applied to rVSV-ZEBOV Ebola vaccine
|
|
15:10 – 15:20
|
Paul Anziani, PhD Student, CIFRE Sanofi - Bioaster - Université de Lyon UCBL (FR)
Multi-omics analyses of Bordetella pertussis fermentation for vaccine bio-production consistency monitoring
|
|
15:20 – 15:30
|
Louis Bourlon, PhD Student, EMJMD LIVE Alumni, CIFRE Sanofi - IAB – CEA - Université Grenoble Alpes (FR)
Vectorization of antigens of interest on lipid nanoparticles for vaccine application
|
|
15:30 – 16:00
|
Coffee break & Kahoot animated by Sakshi Jindal
|
|
16:00 – 18:00
|
Session 5: Controlled human infection modelling (CHIM) - Dennis Giron & Peter Delputte
|
|
16:00 – 16:20
|
Hilde Depraetere, PhD, Director of Operations, European Vaccine Initiative, Heidelberg ( DE)
General considerations on human infection studies
|
|
16:20 – 16:40
(video)
|
Eddie Suvarnapunya, PhD, Infectious diseases researcher/scientist, Walter Reed Army Institute of Research (WRAIR), Rockville, MD (US)
Immune response characterization after controlled infection with lyophilized Shigella sonnei 53G
|
|
16:40 – 17:10
|
Jeffrey Bethony, Professor, Dpt of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC (US)
Hookworm CHIM & Vaccine Development in Brazil
|
|
17:10 – 18:00
|
Adrian Wildfire, Director, Scientific and Business Strategy, Open Orphan / hVIVO, Guildford (UK)
Controlled Human Infection Modelling: Challenges in modelling natural viral diseases
|
|
18:00 – 18:15
|
Closure - Dolores Jaraquemada
|
Deadline May 18 midnight UTC/GMT+2
